By Chen Qide SHANGHAI: Huayi Group plans to invest about 100 million yuan in a pilot project to manufacture a medicine for diabetics that it developed through its own research.

SHANGHAI: The Huayi Group, one of China's leading chemical firms, is expected to invest about 25 billion yuan (US$3.1 billion) between 2006 and 2010 to further push forward the city's chemical industry.